OGN

NYSE · Pharmaceuticals

Organon & Co

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$13.68

-0.01 (-0.07%)

As of Sep 20, 10:06 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 7 54%

Sell 6 46%

Price Target

Analyst Price Target +560.8% upside

Low Target $73.92

Average Target $90.40

High Target $125.40

Current Price $13.68

Current
$13.68

Target
$90.40

$73.92 $90.40 avg $125.40

Scenario Analysis

Bear Case

$73.92

440.4%

Low target

Base Case

$90.40

+560.8%

Avg target

Bull Case

$125.40

+816.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$13.79

-0.8% from high

52-Week Low

$5.69

+140.4% from low

50-Day SMA

$7.87

+73.8% vs SMA

200-Day SMA

$8.85

+54.6% vs SMA

RSI (14)

32.1

Neutral

Target vs 52W High

$90.40

+555.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%